$KYMR
Kymera Therapeutics, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022021543 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $16.14M $9.551M $20.34M
YoY Change 5.66% -53.03% 39.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $11.64M $10.56M $10.67M
YoY Change -0.89% -1.04% 55.95%
% of Gross Profit
Research & Development $43.13M $43.88M $38.31M
YoY Change 14.93% 14.54% 142.78%
% of Gross Profit
Depreciation & Amortization $818.0K $800.00 $700.0K
YoY Change 18.72% -99.89% 40.0%
% of Gross Profit
Operating Expenses $54.77M $54.43M $48.97M
YoY Change 11.16% 11.15% 116.54%
Operating Profit -$44.88M -$28.64M
YoY Change 56.73% 254.29%
Interest Expense $3.765M $1.880M $55.00K
YoY Change 3905.32% 3318.18% -45.0%
% of Operating Profit
Other Income/Expense, Net $1.880M $55.00K
YoY Change 3318.18% -43.3%
Pretax Income -$34.87M -$43.00M -$28.58M
YoY Change 2.85% 50.45% 257.72%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$34.87M -$43.00M -$28.58M
YoY Change 2.85% 50.45% 257.9%
Net Earnings / Revenue -216.03% -450.24% -140.55%
Basic Earnings Per Share -$0.79 -$0.56
Diluted Earnings Per Share -$0.60 -$0.79 -$563.6K
COMMON SHARES
Basic Shares Outstanding 54.86M 51.86M 50.71M
Diluted Shares Outstanding 54.54M 50.71M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $407.2M $481.9M $536.4M
YoY Change -7.97% -10.16% 82.54%
Cash & Equivalents $68.40M $155.7M $156.8M
Short-Term Investments $338.8M $326.3M $379.6M
Other Short-Term Assets $9.713M $9.232M $5.772M
YoY Change 11.39% 59.94% 99.03%
Inventory
Prepaid Expenses
Receivables $2.537M $2.882M $1.573M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $419.4M $494.0M $543.7M
YoY Change -7.06% -9.14% 82.85%
LONG-TERM ASSETS
Property, Plant & Equipment $13.33M $12.57M $12.18M
YoY Change 12.23% 3.16% 10.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $152.3M $113.7M $74.69M
YoY Change 21.68% 52.23% -60.16%
Other Assets $3.017M $3.016M $716.0K
YoY Change 49.21% 321.23% -54.97%
Total Long-Term Assets $183.7M $144.5M $98.72M
YoY Change 18.81% 46.32% -52.99%
TOTAL ASSETS
Total Short-Term Assets $419.4M $494.0M $543.7M
Total Long-Term Assets $183.7M $144.5M $98.72M
Total Assets $603.1M $638.5M $642.5M
YoY Change -0.46% -0.62% 26.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.335M $6.327M $5.033M
YoY Change 8.24% 25.71% 26.49%
Accrued Expenses $27.50M $24.69M $19.22M
YoY Change 19.72% 28.48% 144.08%
Deferred Revenue $35.26M $55.78M $66.23M
YoY Change -42.89% -15.79% -28.02%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.408M $1.103M $1.189M
YoY Change 23.73% -7.23% 69.86%
Total Short-Term Liabilities $71.34M $91.12M $94.49M
YoY Change -22.91% -3.57% -11.92%
LONG-TERM LIABILITIES
Long-Term Debt $1.246M $690.0K $1.347M
YoY Change 9.3% -48.78% 68.38%
Other Long-Term Liabilities $248.0K $256.0K $76.00K
YoY Change 275.76% 236.84% -99.93%
Total Long-Term Liabilities $248.0K $256.0K $76.00K
YoY Change 275.76% 236.84% -99.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.34M $91.12M $94.49M
Total Long-Term Liabilities $248.0K $256.0K $76.00K
Total Liabilities $113.0M $125.6M $159.3M
YoY Change -22.76% -21.17% -25.09%
SHAREHOLDERS EQUITY
Retained Earnings -$383.8M -$348.9M -$195.1M
YoY Change 67.61% 78.83% 68.07%
Common Stock $878.9M $867.7M $678.4M
YoY Change 27.51% 27.91% 65.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $490.2M $512.9M $483.1M
YoY Change
Total Liabilities & Shareholders Equity $603.1M $638.5M $642.5M
YoY Change -0.46% -0.62% 26.63%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$34.87M -$43.00M -$28.58M
YoY Change 2.85% 50.45% 257.9%
Depreciation, Depletion And Amortization $818.0K $800.00 $700.0K
YoY Change 18.72% -99.89% 40.0%
Cash From Operating Activities -$39.54M -$34.27M -$37.26M
YoY Change 3.09% -8.03% -128.29%
INVESTING ACTIVITIES
Capital Expenditures $373.0K -$1.246M -$306.0K
YoY Change -174.45% 307.19% -87.25%
Acquisitions
YoY Change
Other Investing Activities -$49.29M -$36.24M -$136.6M
YoY Change -26.99% -73.47% -58.86%
Cash From Investing Activities -$49.67M -$37.48M -$136.9M
YoY Change -26.98% -72.61% -59.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.953M 150.5M 246.0M
YoY Change -4.92% -38.83% 25.34%
NET CHANGE
Cash From Operating Activities -39.54M -34.27M -37.26M
Cash From Investing Activities -49.67M -37.48M -136.9M
Cash From Financing Activities 1.953M 150.5M 246.0M
Net Change In Cash -87.25M 78.75M 71.92M
YoY Change -16.36% 9.5% -1241.54%
FREE CASH FLOW
Cash From Operating Activities -$39.54M -$34.27M -$37.26M
Capital Expenditures $373.0K -$1.246M -$306.0K
Free Cash Flow -$39.91M -$33.02M -$36.95M
YoY Change 5.44% -10.64% -127.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
690000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
717000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1140000
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54864727
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
256000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
66000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155658000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47976000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
326250000
CY2022Q3 us-gaap Liabilities
Liabilities
125587000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
394442000
CY2022Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2882000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
135000
CY2021Q4 us-gaap Liabilities
Liabilities
146267000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9232000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8720000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Assets Current
AssetsCurrent
494022000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
451273000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
113701000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125187000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12569000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11881000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9048000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54751429
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51573924
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9426000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3016000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2022000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6116000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6116000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54751429
CY2022Q3 us-gaap Assets
Assets
638472000
CY2021Q4 us-gaap Assets
Assets
605905000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51536181
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
39295000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12431000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
KYMR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13224000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromRelatedParties
kymr Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
kymr Net Operating Loss Carryforwards Period Cares Act
NetOperatingLossCarryforwardsPeriodCARESAct
P5Y
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromRelatedParties
kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromRelatedParties
dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2022Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
CY2022Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
kymr Proceeds From Concurrent Private Placement Follow On
ProceedsFromConcurrentPrivatePlacementFollowOn
dei Amendment Flag
AmendmentFlag
false
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2022#RevenueFromRelatedParties
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39460
dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
285-5300
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6327000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4005000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24692000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22971000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
55776000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
61739000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2516000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2461000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1103000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1138000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
710000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
228000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
91124000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92542000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
21086000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
6000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
867717000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
689275000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-348925000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228982000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5913000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-660000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
638472000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
605905000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9551000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20336000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30687000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57557000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43877000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38306000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121115000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
99488000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10556000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10667000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32198000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24605000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
54433000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
48973000
us-gaap Operating Expenses
OperatingExpenses
153313000
us-gaap Operating Expenses
OperatingExpenses
124093000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44882000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-28637000
us-gaap Operating Income Loss
OperatingIncomeLoss
-122626000
us-gaap Operating Income Loss
OperatingIncomeLoss
-66536000
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1916000
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
125000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2800000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
343000
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
36000
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
70000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
117000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
124000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1880000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2683000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
219000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1930000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-146000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-5253000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-18000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44932000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28728000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-125196000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66335000
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-43002000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28582000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-119943000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-66317000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50714846
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50714846
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50714846
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50714846
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841636
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841636
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841636
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841636
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258104000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
258104000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3257000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3257000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7396000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7396000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-146000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-146000
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
CY2021Q3 kymr Stock Issued During Period Value Public Offering Net Of Underwriting Discounts And Costs
StockIssuedDuringPeriodValuePublicOfferingNetOfUnderwritingDiscountsAndCosts
240760000
CY2021Q3 kymr Stock Issued During Period Value Public Offering Net Of Underwriting Discounts And Costs
StockIssuedDuringPeriodValuePublicOfferingNetOfUnderwritingDiscountsAndCosts
240760000
CY2021Q3 kymr Issuance Of Shares In Concurrent Private Placement
IssuanceOfSharesInConcurrentPrivatePlacement
2346000
CY2021Q3 kymr Issuance Of Shares In Concurrent Private Placement
IssuanceOfSharesInConcurrentPrivatePlacement
2346000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
397951000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1096000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
397951000
CY2022Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
CY2022Q3 kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
964000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5875000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16294000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
kymr Stock Issued During Period Value Public Offering Net Of Underwriting Discounts And Costs
StockIssuedDuringPeriodValuePublicOfferingNetOfUnderwritingDiscountsAndCosts
240760000
kymr Issuance Of Shares In Concurrent Private Placement
IssuanceOfSharesInConcurrentPrivatePlacement
2346000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
256000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5253000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
us-gaap Profit Loss
ProfitLoss
-119943000
us-gaap Profit Loss
ProfitLoss
-66317000
us-gaap Share Based Compensation
ShareBasedCompensation
26571000
us-gaap Share Based Compensation
ShareBasedCompensation
16294000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2159000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1708000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
1794000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
4171000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-18000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
512000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1068000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-577000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
2747000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2321000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1082000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1677000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8803000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-24172000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54217000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-378000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-305000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-738000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-794000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
337000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
439000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113549000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90594000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2463000
CY2022Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
CY2022Q3 kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
964000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9076000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1930000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
283888000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5875000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
307000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16294000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16207000
kymr Stock Issued During Period Value Public Offering Net Of Underwriting Discounts And Costs
StockIssuedDuringPeriodValuePublicOfferingNetOfUnderwritingDiscountsAndCosts
240760000
kymr Issuance Of Shares In Concurrent Private Placement
IssuanceOfSharesInConcurrentPrivatePlacement
2346000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
483135000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
174000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
149826000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1790000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
256000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26571000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5253000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
512885000
us-gaap Share Based Compensation
ShareBasedCompensation
26571000
us-gaap Share Based Compensation
ShareBasedCompensation
16294000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2159000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1708000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
1794000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1068000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-577000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
2747000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
717000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2321000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1082000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1677000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8803000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-24172000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54217000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-378000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-305000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-738000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-794000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
337000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
439000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113549000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90594000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2463000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1096000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
298736000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
292006000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
371384000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
261286000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
70185000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31816000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
149825000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1790000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5874000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
256000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
307000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
397000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
825000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
693000
kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
240788000
kymr Proceeds From Concurrent Private Placement Follow On
ProceedsFromConcurrentPrivatePlacementFollowOn
2347000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
151046000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161774000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
us-gaap Interest Paid Net
InterestPaidNet
124000
us-gaap Interest Paid Net
InterestPaidNet
106000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
340000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
65000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
87000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
1918000
kymr Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
28000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155658000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156819000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
6116000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1590000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161774000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-348900000
CY2022Q3 us-gaap Investments And Cash
InvestmentsAndCash
595600
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
298736000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
292006000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
371384000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
261286000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
70185000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31816000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
149825000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants At Private Placement Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsAtPrivatePlacementNetOfIssuanceCosts
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1790000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5874000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
256000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
307000
us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
397000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
825000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
693000
kymr Proceeds From Follow On Offering Net Of Underwriting Discounts And Offering Costs
ProceedsFromFollowOnOfferingNetOfUnderwritingDiscountsAndOfferingCosts
240788000
kymr Proceeds From Concurrent Private Placement Follow On
ProceedsFromConcurrentPrivatePlacementFollowOn
2347000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
151046000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248226000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107682000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
125816000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32593000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161774000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
340000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
65000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
87000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
1918000
kymr Offering Costs Included In Accrued Liabilities
OfferingCostsIncludedInAccruedLiabilities
28000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155658000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156819000
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
6116000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
1590000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
158409000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
79
CY2021Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
394400000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
37
CY2022Q3 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0195
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
445845000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5905000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
439951000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
520286000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
658000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
519629000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
159
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
426900000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
113
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
515400000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
106
CY2022Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
326300000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
57
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
113700000
CY2022Q3 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2022Q3 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2021Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
445845000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5905000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
439951000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
520286000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
658000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
519629000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
159
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
426900000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
113
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
515400000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
106
CY2022Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
326300000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
57
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
113700000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
79
CY2021Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
394400000
CY2021 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
37
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125200000
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2022Q3 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2021Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
125200000
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2022Q3 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2021Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
3800000
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2900000
kymr Collaboration Termination Date
CollaborationTerminationDate
2022-04-27
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
135000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
10283000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
7536000
CY2022Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
2882000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
101034000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
6515000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-30687000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
76862000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18644000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15797000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6075000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3916000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12569000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11881000
CY2022Q3 us-gaap Depreciation
Depreciation
800
CY2021Q3 us-gaap Depreciation
Depreciation
700
us-gaap Depreciation
Depreciation
2200
us-gaap Depreciation
Depreciation
1700
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
297000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
279000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
855000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
650000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
39000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
52000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
124000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
106000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
297000
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
3800000
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2900000
kymr Collaboration Termination Date
CollaborationTerminationDate
2022-04-27
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
135000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
10283000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
7536000
CY2022Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
2882000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
101034000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
6515000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-30687000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18644000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15797000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6075000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3916000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12569000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11881000
CY2022Q3 us-gaap Depreciation
Depreciation
800
CY2021Q3 us-gaap Depreciation
Depreciation
700
us-gaap Depreciation
Depreciation
2200
us-gaap Depreciation
Depreciation
1700
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
900000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
524000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
524000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
us-gaap Operating Lease Cost
OperatingLeaseCost
1571000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
297000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
279000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
855000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
650000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
39000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
52000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
124000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
106000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
297000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
358000
us-gaap Variable Lease Cost
VariableLeaseCost
870000
us-gaap Variable Lease Cost
VariableLeaseCost
743000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1157000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
358000
us-gaap Variable Lease Cost
VariableLeaseCost
870000
us-gaap Variable Lease Cost
VariableLeaseCost
743000
CY2022Q3 us-gaap Lease Cost
LeaseCost
1157000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1213000
us-gaap Lease Cost
LeaseCost
3420000
us-gaap Lease Cost
LeaseCost
3070000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1931000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2060000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
833000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
593000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
124000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
106000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
650000
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
287000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2659000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1097000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2732000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
75000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2898000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M2D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M21D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M9D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1050
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1050
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0873
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0875
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
650000
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
287000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2659000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1097000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2732000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1213000
us-gaap Lease Cost
LeaseCost
3420000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1931000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
2060000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
593000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
124000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
106000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M2D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M21D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M9D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1050
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0875
CY2022Q3 kymr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
10027000
CY2022Q3 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21780000
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1932000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6833000
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
139000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14947000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1793000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
473000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2814000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
75000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2898000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
1932000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6833000
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
139000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
14947000
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1793000
CY2022Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16762000
CY2021Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15169000
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6160000
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6033000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1577000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1417000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
193000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22971000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
CY2022Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16762000
CY2021Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15169000
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6160000
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6033000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1577000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1417000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
193000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
352000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24692000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22971000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0301
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0091
us-gaap Net Income Loss
NetIncomeLoss
-66317000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50714846
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M2D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M2D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.66
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0301
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0091
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0195
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9076000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26571000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16294000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50714846
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841636
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9076000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26571000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16294000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-43002000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28582000
us-gaap Net Income Loss
NetIncomeLoss
-119943000
us-gaap Net Income Loss
NetIncomeLoss
-66317000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54535514
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54535514
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50714846
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50714846
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52600103
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52600103
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46841636
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841636
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7291922
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6680923
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46841636
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7291922
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6680923

Files In Submission

Name View Source Status
0000950170-22-021543-index-headers.html Edgar Link pending
0000950170-22-021543-index.html Edgar Link pending
0000950170-22-021543.txt Edgar Link pending
0000950170-22-021543-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kymr-20220930.htm Edgar Link pending
kymr-20220930.xsd Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
kymr-20220930_def.xml Edgar Link unprocessable
kymr-20220930_cal.xml Edgar Link unprocessable
kymr-20220930_pre.xml Edgar Link unprocessable
kymr-20220930_lab.xml Edgar Link unprocessable
kymr-20220930_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable